Clinical AI Model for Lung Cancer: PD-L1

CE | Lung | Amplifier Integrator | PD-L1

Description of use

The Aiforia Clinical AI Model for Lung Cancer: PD-L1 can automatically detect cancerous areas in patient samples for the pathologist to review. Using Aiforia’s browser-based software the pathologist is then able to rapidly calculate PD-L1, even in cases of weak expression of the biomarker or small foci of cancer. The user can quickly locate, zoom in and review the critical areas to confirm the AI model’s evaluation.

The AI Model enables viewing and selection of areas with high density of PD-L1-positive cells (“hotspots”) and displays results of image analysis. A medical professional can view images for a patient case in different magnifications and move in different x-y-z-locations, view image analysis results, and mark and measure features in the images. The product supports the user's visual interpretation and assists the medical professional in making the diagnosis.

The AI model is an aid to diagnosis but is not the sole basis for diagnosis. Medical professionals have the full responsibility for the clinical report.

The application content is provided by the respective AI vendors.